Ehave, Inc. (EHVVF)

[greenwillow]

We believe that the cannabis industry lacks comprehensive data for clinicians to draw from when advising patients on treatment plans, as well as reliable systems to track outcomes. Ehave may enable more accurate and efficient study of cannabis and help establish objective guidelines that clinicians can rely upon when prescribing cannabis therapies.

We Seek to Answer Common Questions and Concerns:
Is cannabis the right therapeutic to prescribe?
What is the most effective strain for a particular condition?
What is the appropriate dose or delivery method for a particular condition?
How does a clinician compare treatment options?
How can clinicians ensure that patients are using the product as prescribed?
How do patients know their prescription is working the way its supposed to?
Do payors have the right reimbursement criteria?
Where should licensed producers concentrate their research and development efforts?


THE EHAVE PLATFORM
Some evidence suggest that cannabis may benefit some persons suffering from mental health conditions. However, clinicians are trained to make medical suggestions based on robust clinical data which is lacking in the emerging field of cannabis.

An evidence-based approach is needed to conclusively determine the medical benefits of cannabis – the results of this research may drive clinician and patient adoption of cannabis. Additionally, more research is needed to characterize the compounds found within cannabis that may offer therapeutic benefits – this could maximize the benefits of cannabis while potentially reducing unwanted side effects.

Ehave is proud to offer a mental health informatics platform that seeks to empower patients, clinicians, and researchers with the tools needed to monitor every step of the cannabis treatment life cycle, from diagnosis and treatment planning to outcomes verification.

https://www.ehave.com/solutions/cannabis/